By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital ...
When the monkeys were single-celled embryos, scientists had used CRISPR editing tools to silence, or “knock out”, a gene that ...
Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Like recombinant DNA before it, gene editing has the potential to transform medicine, agriculture and more. CRISPR is now used by thousands of biologists in labs across the globe. A revolution in food ...
A strong perception of experiencing discrimination correlates with differences in human gene expression by race and sex.
A repaving project in the city of Palm Springs continues to cause major headaches for commuters.  Cal Trans crews have been ...
The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...
A genetic study published on Tuesday offers an important new clue. Researchers found that, between 250,000 and 500,000 years ...